Intrahepatic cholestasis of pregnancy, second trimester
ICD-10 O26.642 is a billable code used to indicate a diagnosis of intrahepatic cholestasis of pregnancy, second trimester.
Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that occurs during pregnancy, characterized by intense itching and elevated bile acids in the bloodstream. It typically arises in the second or third trimester and is associated with increased risks for both the mother and fetus, including preterm birth and fetal distress. The condition is believed to be related to hormonal changes and genetic predisposition, leading to impaired bile flow. Maternal symptoms often include pruritus, particularly on the palms and soles, and may be accompanied by jaundice in more severe cases. Diagnosis is confirmed through blood tests showing elevated liver enzymes and bile acids. Management focuses on symptom relief and monitoring fetal well-being, with potential interventions including medication to reduce bile acid levels and early delivery if necessary. Close collaboration with obstetricians and maternal-fetal medicine specialists is essential for optimal outcomes.
Detailed documentation of maternal symptoms, laboratory results, and treatment plans is essential for accurate coding.
Patients presenting with itching and elevated bile acids, requiring monitoring and potential early delivery.
Consideration of the timing of symptoms and their impact on delivery planning.
Comprehensive documentation of high-risk factors, fetal monitoring results, and interdisciplinary consultations.
Management of patients with ICP who are at risk for fetal distress or preterm labor.
Focus on the implications of ICP on fetal health and the need for potential interventions.
Used for routine follow-up visits for patients with ICP.
Documentation of symptoms, lab results, and management plan.
Obstetricians should ensure thorough documentation of all relevant findings.
Common symptoms include intense itching, particularly on the palms and soles, and in some cases, jaundice. These symptoms typically arise in the second or third trimester and can significantly impact the quality of life for the mother.
